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Uncle Sam's Debut on the Value-Based Purchasing Stage
In the fall of 2006, Secretary Michael Leavitt of the US Department of
Health and Human Services announced with great fanfare that Uncle
Sam was going to become a value-based purchaser of health benefits.
An article in this issue of VBP highlights how the Centers for Medicare
and Medicaid Services (CMS) has begun to implement this vision in
the Medicare program, starting with an emphasis on hospital inpatient
services, but branching out to affect all health care services, including
physician services. Now that the “600 pound gorilla” has entered the
game, many employers, and indeed some Benefits College alumni,
may be wondering what this means for your own benefits purchasing
strategy.
In answering that question, I’m reminded of how I first ended up
partnering with Jerry Burgess and Andy Webber in the development of
the College for Advanced Management of Health Benefits. Our
Jefferson Department of Health Policy was engaged in research,
supported by the Commonwealth Fund, examining whether the “value
based purchasing movement had legs,” i.e. did employers really care
about quality? Our initial findings, published in a Fund report, included
the important assessment that employers were starting to care about
quality and value, and that they played a pivotal role in shaping policy.
Government might have the economic and political power to influence
the market, but it would not exercise that power in the absence of
proven interventions. The employer-led value-based purchasing
movement was, and remains, an essential driver in developing, testing,
and disseminating quality and value-improving interventions that
government can then adapt and implement on a national scale.
As CMS moves forward with its VBP initiatives, the employer and
coalition imperative to work at the local level remains strong. Work is
still needed to answer a myriad of important questions not readily
approachable by the “big G”, for example:
•

How can quality and value data be used to drive appropriate careseeking by consumers?

•

How can the principles of “value-based
benefit design” move beyond modifying
drug co-payments to a broader range of
value-linked benefit offerings?

•

To what extent is the current wellness
fad going to translate into true health
improvement and cost-savings?

•

care purchaser, spent an estimated $425
billion on health services in 2007. With the
projected growth in Medicare beneficiaries, the
amount may surpass $800 billion by 2017,
placing the government under significant
pressure to control health care costs. 3
This article is intended as a brief summary of
the Centers for Medicare and Medicaid
Services’ (CMS) experience and its
prospective strategies for health care quality
improvement, including relevant legislation and
potential future trends for value-based
programs under CMS.

How can employers work in partnership
with providers and other community
members to best promote value?

The list of important questions is clearly much
broader and deeper. Government plays an
important role in dissemination, but employers
remain the central agents in figuring out what
works (and what doesn’t) – and sharing those
experiences through publication, presentation
at conferences, and networking with
colleagues and coalitions. I hope that you will
read this issue of Value Based Purchasing,
and then get back to the important work at
hand.

Initially, the Medicare payment system was
based on provider claims for “customary,
reasonable, and necessary costs.” In the
1980’s, Medicare introduced a prospective
payment system for hospitals based on
Diagnosis-Related Groups (DRG), but
maintained a fee-for-service payment for
ambulatory services. This payment system
rewards providers for volume of services rather
than the quality of those services, and
encourages high resource consumption rather
than efficient health care delivery. An
increasing body of evidence 2 has revealed
wide variations in quality and costs for the
health care services provided to Medicare
beneficiaries.

Neil Goldfarb, Editor
Value-Based Purchasing

The Centers for Medicare and
Medicaid Services’
Approach to Value-Based Purchasing

Armed with this knowledge, CMS developed a
“Roadmap for Quality,” aimed at “transforming
Medicare from a passive payer to an active
purchaser of high quality efficient care.”4 In an
effort to take a leadership role in transforming
the health care system by supporting the
Institute of Medicine’s (IOM) 6 aims for health
care (ie, Safe, Effective, Patient-centered,
Timely, Efficient, and Equitable), CMS adopted
the following strategies for achieving high
quality, patient centered care:

Bettina Berman, RN
Although evidence suggests that both the
quality and the affordability of health care can
be improved1, it is likely that such
improvements will come at great cost.
Healthcare expenditures in the United States
(U.S.) are expected to rise precipitously - from
$1.5 trillion in 2005 to over $4 trillion in 2016. 2
Medicare, the nation’s single largest health
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1. Work through partnerships
2. Publish quality measurement and
information
3. Pay in a way that expresses a
commitment to quality and rewards
rather than inadvertently punishing
providers and practitioners for doing the
right thing
4. Promote health information technology
5. Become an active partner in creating
and using information about the
effectiveness of healthcare technologies

phase out Medicare’s current Reporting of
Hospital Quality Data for Annual Payment
Update Program (RHQDAPU). Under the new
program, up to 5 percent of hospital payments
would be made on the basis of a total
performance score derived from measures that
evaluate both clinical care and patient
satisfaction.
In December of 2006, President Bush signed
the Tax Relief and Health Care Act (TRHCA),
paving the way for the Physician Quality
Reporting Initiative (PQRI), a voluntary pay-forreporting system aimed at individual physician
and non-physician providers of Medicare
services. The 2007 PQRI program, consisting
of 74 measures, went into effect on July 1,
2007. For 2008, the PQRI incorporates 119
measures of clinical care, resource utilization,
and structural measures (eg, electronic health
records). Quality codes (CPT-II codes) are
linked to the diagnostic codes (CPT-I and/or
ICD-9) and submitted through the claims
system. In order to qualify for a bonus of up to
1.5% of the total allowed charges for Medicare
services, providers must reach a reporting
compliance of 80%. Bonus payments and
feedback reports from CMS, including reporting
and performance rates, are expected by mid2008.
According to CMS, the future of Medicare
reimbursement for all payment systems is
value-based purchasing .7 Future development
of value-based purchasing programs for
hospitals includes an emphasis on
development of efficiency measures. For
physicians, CMS is currently exploring the
feasibility of providing resource utilization
reports for individual providers. Another area
being investigated by CMS is an “episode of
care” payment system that offers an incentive
to physicians who provide both wellcoordinated and cost-effective care8 for
individual Medicare beneficiaries.

The Deficit Reduction Act of 2005 (DRA)
required a quality adjustment in Medicare
Diagnosis Related Group (DRG) payment for
certain hospital-acquired conditions (HAC),
including serious preventable events, pressure
ulcers, falls, and vascular catheter-associated
infections. The legislation also authorized the
development of a plan for a hospital valuebased program to commence in FY 2009. CMS
has received support for the value-based plan
from multiple stakeholders, including private
insurers, the National Quality Forum (NQF),
and the Medicare Payment Advisory
Commission (MedPAC).
In its report, “Rewarding Provider
Performance”5, the IOM recommended that
“the Secretary of the Department of Health and
Human Services (DHHS) should implement
pay for performance in Medicare using a
phased approach as a stimulus to foster
comprehensive and system wide
improvements in the quality of health care.”
The report recommended transparency and
incentive measures, stating that such
measures will likely improve health care
quality, but not necessarily reduce costs.
The final plan for a hospital payment system
based on value was presented to the Congress
in November of 2007. 6 The plan proposes a
value-based program which will eventually
Value-Based Purchasing Newsletter
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Bettina Berman, RN is the Project Director for
Quality Improvement in the Department of
Health Policy at Jefferson Medical College.
She can be reached at:
Bettina.Berman@jefferson.edu.

The Emerging Role of Electronic
Medical RecordsWhat Do They Mean to Quality and
Value?
Richard Jacoby, MD
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President Bush identified electronic medical
records (EMRs), also known as electronic
health records (EHRs), as one of the 4
cornerstones in his value driven health care
initiative.1 EMRs represent a “disruptive
technology” insofar as they change the way we
capture, store, retrieve, share, and use health
information. Because they have the ability to
transform and enhance virtually all
communications, transactions, and analyses
involving healthcare information,
implementation of EMRs will have a profound
effect on patients, providers, and payers. The
transformation likely will parallel the one which
occurred as information technology enhanced
knowledge and productivity in the nonhealthcare segments of the U.S. economy. As
such, the potential of EMRs to have a
significant and positive impact on quality and
value in healthcare is great.
That being said, it is well known that the
information generated by a system is only as
good as the data entered into it (ie, “garbage
in-garbage out”). Whether captured in
electronic format or on paper, much of the
information contained in medical records that
relates to quality and value is entered by
physicians. For a physician to enter
“appropriate” information, he or she must be
aware of the type of information being sought.
After all, it is the knowledge base and thought
processes of physicians that interact to result
in the decisions and behaviors that are
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billing records, advanced directives, living wills,
and health powers of attorney.

documented in a medical record. If physicians
lack the knowledge or education in quality
metrics, the concept of value in healthcare, and
the mechanics of EMR use, they are unlikely to
capture the required data.

Some important “value added” features of
EMRs (i.e., unavailable in paper based
records) include:

In what now is a classic paper on the quality of
healthcare delivered to patients in the United
States, researchers at the Rand Corporation
found that recommended care that adhered to
widely agreed upon evidence-based guidelines
was delivered just 54.9% of the time.2
Logically, if nothing were to change other than
records being kept electronically instead of on
paper, and such a study of quality were
repeated, there is no reason to assume that
quality performance would improve. A major
study recently published in the Archives of
Internal Medicine supported this premise. The
study comparing quality measures pre and
post EMR implementation showed no
difference in 14 measures, improvement in 2
measures, and worse performance on 1
measure.3 It is with caution then that we
proceed further with this discussion of the role
of EMRs and what they mean to quality and
value.

•

•
•

•

In my opinion, these additional features hold
the key to unlocking the capabilities of EMRs to
improve quality and value in the American
healthcare system through their ability to help
change and augment physician decision
making.
What will it take for EMRs to impact quality
and value on a national scale?

What is an EMR?

First, EMRs must become more widely utilized.
In the most comprehensive study to date that
reliably measures the state of EMR use by
doctors and hospitals, researchers from
Massachusetts General Hospital (MGH) and
George Washington University (GWU)
estimate that 1 in 4 doctors (24.9 percent) use
EMRs to improve how they deliver care to
patients. However, less than 1 in 10 are using
what experts define as a "fully operational"
system that collects patient information,
displays test results, allows providers to enter
medical orders and prescriptions, and helps
doctors make treatment decisions.4 The same
study found that “hospital adoption trends are

Currently, there is no standard definition. In
simple and practical terms however, whether
used in the hospital (inpatient) or ambulatory
(outpatient) setting, an EMR is a medical
record that has been captured in a digital
format. It may include data relating to patient
demographics, medical history, physical
examination and progress reports of health and
illnesses, medication and allergy lists,
immunization status, laboratory test results,
radiology images, clinical photographs, a
record of appointments and other reminders,

Value-Based Purchasing Newsletter

Computerized provider order entry systems
(CPOE), which include computerized orders
for prescriptions (“e-prescribing”),
Computerized reporting of test results,
Clinical decision support systems, which
may facilitate medical decision-making and
provide evidence-based recommendations
for specific medical conditions, and
Computer generated prompts and
reminders.
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3. Electronic Health Record Use and the Quality of
Ambulatory Care in the United States, Jeffrey A.
Linder, et al., Arch Intern Med. 2007;167:1400-1405.
4. Available at
http://www.rwjf.org/newsroom/newsreleasesdetail.js
p?productid=21882.
5. Ibid.
6. Available at:
http://healthit.ahrq.gov/portal/server.pt?open=514&o
bjID=5562&mode=2&holderDisplayURL=http://prodp
ortallb.ahrq.gov:7087/publishedcontent/publish/com
munities/a_e/ahrq_funded_projects/test_emerging_l
essons/health_briefing_12282006111136/electronic
_health_records.html. Accessed 2/11/08.

unknown. Assertions to the contrary, there are
not enough high-quality, reliable surveys of
hospital use of EHRs. The research team
reliably estimates, however, that about 5
percent of America's 6,000 hospitals have
adopted computerized physician order entry
(CPOE) systems, a component of EHRs, to
help reduce medical errors and ease care
delivery.”5
I don’t think EMRs will impact quality and value
on a national scale until a critical mass of
physicians is using “fully operational” systems.
In Donabedian parlance, once the “structure” is
in place, physicians can and need to be
educated on the “processes” of quality and
value which can result in the desired
“outcomes” of enhanced quality and value.
To achieve these outcomes, everyone involved
with EMR implementation must appreciate that
“implementation of health information
technology (health IT) is one-third technology
and two-thirds organizational culture and work
process.” 6 Physicians and the whole care
team must embrace this process if the potential
of EMRs to enhance quality and value in
healthcare is to be realized.

Challenges and Benefits in Using
Productivity Data from
Clinical Trials for VBP Decisions
Thomas J. Bunz, PharmD and
Laura T. Pizzi, PharmD, MPH
Making value based purchasing decisions in
healthcare requires balancing data from
several sources. Information on effectiveness
of interventions often comes from clinical trials,
with less reliance on observational studies.
Historically, the opposite has been true of
information on the cost of interventions. More
recently, providers of healthcare interventions
such as drugs, devices, and disease
management programs have begun to
understand and appreciate the importance of
costs in healthcare decision making. Because
of this, the clinical trials used to demonstrate
effectiveness have begun to gather data on
costs. This article describes some benefits
and detriments of collecting cost data as a
component of clinical trials, focusing
specifically on the data related to productivity.

Dr. Jacoby is Project Director and Clinical
Associate Professor in the Department of
Health Policy at Jefferson Medical College. He
can be reached at:
richard.jacoby@jefferson.edu.
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Studies evaluating the cost of an intervention
can look at a variety of different types of costs
depending on the perspective of the study. For
Value-Based Purchasing Newsletter
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an organization whose sole function is to pay
for healthcare (e.g., Pharmacy Benefits
Managers), the direct costs (e.g., the price of a
pharmaceutical) are the only ones with
importance. For employers, it is essential to
consider the indirect costs and, in particular,
productivity.

of medical interventions on health because
they control for a lot of potentially confounding
issues. In these trials, patients are carefully
controlled on one or more specific
interventions, and the outcomes are measured
prospectively. This allows researchers to
arrive at strong conclusions about the causes
and effects observed in the trial.

Productivity can be measured in a variety of
ways, but it is usually reported as an amount of
productivity lost due to a certain disease, or the
amount of productivity loss avoided by using a
specific type of intervention. Productivity loss
due to medical conditions can present itself in
2 ways. The first is absenteeism, often
measured by means of reviewing employee
records of sick days or disability leave.

There are also some limitations when using
clinical trials to measures productivity changes
due to medical interventions. First, one must
recognize that health is only one of many
factors that contribute to work productivity.
Changes observed during a clinical trial may
not be due entirely to the intervention being
tested. In addition, some individuals choose
their jobs, at least in part, in order to mitigate
the limitations of that condition. For example, a
retail worker with back pain may choose to look
for a job at a pharmacy rather than a home
improvement store in order to lessen the
likelihood of heavy lifting as a job requirement.
This type of decision lessens the perceived
impact of a medical intervention on productivity
from a clinical trial point of view.

The second type of productivity loss presenteeism - is more difficult to measure.
Presenteeism is defined as an employee being
present at the work place but unable to perform
at his or her usual level of productivity. This
type of productivity loss is often measured by
surveying employees with certain conditions.
The employees are asked to report the percent
of time they have lost from work as a result of
their condition.

Interpreting studies that evaluate the impact of
medical interventions on productivity can be
difficult, but it is an essential step in
understanding the effect of purchasing
decisions on employees. For instance, it is
important to understand how the conditions in
which the study was conducted differ from
those at the company purchasing the medical
intervention. The type of work being done as
well as the demographic characteristics of the
workers may influence the estimation of wages
for those workers.

The value of lost productivity can be calculated
through either the friction cost approach, or the
human capital approach. The human capital
approach yields estimates of wages lost for the
time that an employee was not working. The
friction cost approach adds to that the cost of
recruiting and training additional labor to
replace that which was lost. Depending on the
condition and the characteristics of the work
environment, either of these approaches may
be appropriate.

Although it has been demonstrated that
productivity loss is one of the largest diseaseassociated costs for employers, we are still in
the early stages of measuring productivity
gains due to specific interventions. As this

Using clinical trials to measure changes in
productivity due to a medical intervention has a
number of benefits. These trials are viewed as
the gold standard for understanding the impact
Value-Based Purchasing Newsletter
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important information becomes more available,
employers should recognize its value in making
purchasing decisions. It is equally important
that the consumers of this information
understand the benefits and detriments of
these study designs.

Benefits College
Program Schedule for 2008
The College for Advanced Management of
Health Benefits will be hosting 3 course
sessions in 2008. By the time you read this,
the first session, in Nashville, Tennessee,
hosted by the HealthCare21 Business
Coalition, will have just been held. The two
additional sessions for the year are:

Thomas J. Bunz, PharmD is a Research
Instructor in the Department of Health Policy at
Jefferson Medical College. He can be reached
at: thomas.bunz@jefferson.edu
Laura T. Pizzi, PharmD, MPH is a Division
Director and Associate Professor in the
Department of Health Policy at Jefferson
Medical College. She can be reached at:
laura.pizzi@jefferson.edu

From the Alumni Network

•

June 2-5, 2008, in Orlando, Florida,
hosted by the Florida Health Care
Coalition

•

September 15-18, 2008 in Arlington,
Virginia (just outside of Washington
DC), hosted by the Virginia Business
Coalition on Health and the Mid-Atlantic
Business Group on Health.

As always, the programs are open to all
interested direct purchasers of health benefits,
and those who act as agents on their behalf
(e.g. brokers and benefit consultants). For
more information, visit
http://www.hc21.org/CAMHB/college_index.ht
m, or contact neil.goldfarb@jefferson.edu.

Missy Jarrott, Director of Human Resources for
Chatham Steel Corporation writes:
“Do you know of any employers who offer
wellness programs that hold the employee and
the spouse accountable for reaching a certain
level of optimum health by means of lower
premiums, specific plan designs, etc.? We
currently hold our employees accountable;
however, we hope to reach spouses in 2009.
Any suggestions?”
Feel free to write to Missy directly at
Missy_Jarrott@chathamsteel.com. We also
would be happy to post your responses in the
next issue of VBP, so please copy
neil.goldfarb@jefferson.edu.
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